Intervention not reported
Adverse events Participants (n) reported serious adverse events · patients with treating osteoarthritis
1 finding from 1 review
- no estimate extracted1 study · 96 participantsGRADE not reported
Findings
What do systematic reviews say?
11 questions · 11 findings · 2 reviews · Musculoskeletal
No studies found 5 · 45.5%GRADE not reported 4 · 36.4%Very low 0 · 0%Low 1 · 9.1%Moderate 1 · 9.1%High 0 · 0%
Intervention not reported
Adverse events Participants (n) reported serious adverse events · patients with treating osteoarthritis
1 finding from 1 review
- no estimate extracted1 study · 114 participantsGRADE not reported
Intervention not reported
Adverse events Participants (n) reported serious adverse events · patients with treating osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Boswellia serrata vs valdecoxib
Adverse events Participants (n) reported serious adverse events · patients with treating osteoarthritis
1 finding from 1 review
- no estimate extracted1 study · 66 participantsGRADE not reported
Intervention not reported
Adverse events Participants (n) reported serious adverse events · patients with osteoarthritis
The intervention showed no clear difference in adverse events Participants (n) reported serious adverse events (moderate certainty).
1 finding from 1 review
- RR 1.22 [0.94, 1.59]1 study · 398 participantsModerate
Intervention not reported
Adverse events Participants (n) reported serious adverse events · patients with osteoarthritis
1 finding from 1 review
- no estimate extracted1 study · 174 participantsGRADE not reported
Intervention not reported
Adverse events Participants (n) reported serious adverse events · patients with treating osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Persea gratissma + Glycine max (ASU 300 mg) vs chondroitin sulphate
Adverse events Participants (n) reported serious adverse events · patients with osteoarthritis
Persea gratissma + Glycine max (ASU 300 mg) showed no clear difference in adverse events Participants (n) reported serious adverse events compared with chondroitin sulphate (low certainty).
1 finding from 1 review
- RR 2.92 [0.31, 27.78]1 study · 357 participantsLow
Intervention not reported
Adverse events Participants (n) reported serious adverse events · patients with osteoarthritis of the knee
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Intervention not reported
Adverse events Participants (n) reported serious adverse events · patients with osteoarthritis of the knee
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Arnica vs ibuprofen
Adverse events Participants (n) reported serious adverse events · patients with hand osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found